SCLEROSOL Drug Patent Profile
✉ Email this page to a colleague
When do Sclerosol patents expire, and what generic alternatives are available?
Sclerosol is a drug marketed by Sciarra Labs and is included in one NDA.
The generic ingredient in SCLEROSOL is talc. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the talc profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sclerosol
A generic version of SCLEROSOL was approved as talc by SCIARRA LABS on December 15th, 2003.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SCLEROSOL?
- What are the global sales for SCLEROSOL?
- What is Average Wholesale Price for SCLEROSOL?
Summary for SCLEROSOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 291 |
| What excipients (inactive ingredients) are in SCLEROSOL? | SCLEROSOL excipients list |
| DailyMed Link: | SCLEROSOL at DailyMed |
US Patents and Regulatory Information for SCLEROSOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciarra Labs | SCLEROSOL | talc | AEROSOL;INTRAPLEURAL | 020587-001 | Dec 24, 1997 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
